CIK 0001124105 · Accelerated filer<br>Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562020050
- Phone
- (858) 284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- FWP Offering Free Writing Prospectus
- S-1/A Offering Registration Statement
- SC 13D/A Stake Beneficial Ownership Report
- CT ORDER Other Confidential Order
- S-1 Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Bylaws or fiscal year change · Other events
- 8-K Event Shareholder vote results
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
Page 40 of 81 · 1,604 filings